Canada: Federal Court Holds Issued Patent Valid Despite Erroneous Issue Fee Payment

In a February 4, 2016 decision, Apotex Inc v Pfizer Inc ("Apotex"), 2016 FC 136, the Federal Court found that an erroneous underpayment of a "final fee" to issue a patent did not invalidate the issued patent. In so doing, the Court distinguished between substantive breaches of the statute that go to the heart of the patent and administrative breaches of the statute in dealings with the Canadian Intellectual Property Office (CIPO).


Once a patent application is deemed to comply with the Patent Act and the Patent Rules, CIPO issues a notice of allowance which requires the applicant to pay a final fee for issuance of the patent. The Rules currently outline two tiers of fees, one for "small entities" and a higher fee for entities other than small entities, i.e., "large entities". If the final fee is not paid within six (6) months of the notice of allowance, the application is "deemed abandoned" under s. 73(1)(f) of the Act.

In Apotex, the Federal Court considered whether an erroneous final fee payment could invalidate a subsequently issued patent. Pfizer is the current owner of Canadian Patent No. 1,339,132 (the '132 patent) which was issued on July 29, 1997 and is directed to latanaprost, a drug used for the treatment of glaucoma and marketed in Canada as XALATAN. The final fee was erroneously paid based on small entity status and the Court found that no "top-up" fee for large entity was ever paid.

Apotex brought a motion for partial summary judgment, alleging that the final fee was not paid in full, that Pfizer failed to correct this issue within the prescribed time period and that, since this final fee was a prerequisite for valid issuance, the '132 patent was invalid.

Does the failure to submit the proper final fee payment invalidate an issued patent?

To answer this question of law, the Court addressed two conflicting lines of jurisprudence. In the Dutch Industries Ltd v Canada ("Dutch Industries"), 2001 FCT 879, aff'd 2003 FCA 121, line of cases, the Federal Court and the Federal Court of Appeal found that the Commissioner lacked the statutory authority to accept top-up payments for maintenance fees after the six-month deadline where a large entity applicant erroneously paid maintenance fees as a small entity. Under the Dutch Industries rationale, any error in the determination of small entity status, "could lead to the loss of all rights under the patent application and any resulting patent, unless the error is discovered and corrected within the statutory time limits for late fee payments".

Apotex relied on the Dutch Industries line of cases to argue that Pfizer had lost all its rights under the patent application and the resulting '132 patent when it failed to pay the full final fee required for the patent to issue.

The Court rejected Apotex's argument. The Court pointed out that the Dutch Industries line of cases only applied to patent applications and that the distinction between the status of a patent application and the status of an issued patent was a well-established principle in the jurisprudence. The Court followed the holding of the Federal Court of Appeal in Corlac Inc v Weatherford Canada Inc, 2011 FCA 228 ("Weatherford") which held that non-compliance with s. 73(1)(a) of the Act during prosecution of a patent application did not invalidate a subsequently issued patent. The Court further noted that any contradiction between Weatherford and the Dutch Industries line of cases should be resolved in favor of the more recent Weatherford decision.

Apotex argued that Weatherford should not be followed since Weatherford dealt with s. 73(1)(a) of the Act and was concerned with whether there had been a failure to respond in good faith to a request by an Examiner, but did not relate to the non-payment of the prescribed fees under s. 73(1)(f) of the Act. Apotex added that the Patent Act in force at the time of filing of the '132 patent was concerned with a patent application being "forfeited" rather than "deemed to be abandoned" if the final fee was not paid.

The Court rejected Apotex's arguments and held that the various subsections in s. 73(1) of the Act were not so different so as not to carry over the teachings from Weatherford from s. 73(1)(a) to 73(1)(f) of the Act. The Court also found that there was no meaningful distinction between the concepts of "forfeiture" under the pre-1996 Patent Act and "deemed abandonment" under the current Act.

More generally, the Court held that there was a fundamental difference between substantive breaches of the statute that go to the heart of the patent bargain and administrative breaches of the statute in dealings with CIPO. The various grounds of invalidity of issued patents go to the heart of the patent bargain between the inventor and the state and constitute substantive breaches which can invalidate issued patents. Administrative breaches such as regarding payment of fees on the other hand can only be fatal to patent applications and cannot invalidate an issued patent.

The Court ultimately concluded that the '132 patent was not invalid for failure to pay the correct final fee and the motion for summary judgment was granted in favor of Pfizer.

Case status

Apotex has appealed the decision to the Federal Court of Appeal.

The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.